SNT 8.33% 3.9¢ syntara limited

Ann: Boehringer Ingelheim discontinues development of BI 1467335, page-6

  1. 1,390 Posts.
    lightbulb Created with Sketch. 218
    Certainly is a penny dreadful.
    What projects have they go on the go now to justify there staff & overheads.
    Everything they do falls in a heap.
    Has been a dud for many many years.

 
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.